Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Parkinson's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of ND0612 Infusion vs. Oral Treatment for Parkinson's Disease Patients with Motor Fluctuations

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Carbidopa

Contact Research Centre

Huntington's disease

Not recruiting

Investigational

Study on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease

Investigational

Austria

Participants:18–64 years
Substances:Tominersen

Contact Research Centre

Cervix carcinoma

Not recruiting

Registered drug

Study of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

B-cell small lymphocytic lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Colitis ulcerative

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Obefazimod

Contact Research Centre

Pulmonary hypertension

Not recruiting

Investigational

Study on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Ralinepag

Contact Research Centre

Parkinson's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine

Contact Research Centre

Pulmonary hypertension

Not recruiting

InvestigationalNo placebo

Study on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Ralinepag

Contact Research Centre

Parkinson's disease

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of ND0612 (Carbidopa, Levodopa) Infusion for Patients with Advanced Parkinson's Disease

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Carbidopa

Contact Research Centre

Cystic fibrosis

Not recruiting

Registered drugNo placebo

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Registered drugNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deutivacaftor

Contact Research Centre

Find therapies in clinical trials near you – page 25

362 trials match your criteria

Myasthenia gravis

Study on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis

Hidradenitis

Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Parkinson's disease

Study on the Effectiveness and Safety of ND0612 Infusion vs. Oral Treatment for Parkinson's Disease Patients with Motor Fluctuations

Huntington's disease

Study on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease

Cervix carcinoma

Study of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer

B-cell small lymphocytic lymphoma

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Colitis ulcerative

Long-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Pulmonary hypertension

Study on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension

Parkinson's disease

Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease

Pulmonary hypertension

Study on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension

Parkinson's disease

Study on the Long-Term Safety of ND0612 (Carbidopa, Levodopa) Infusion for Patients with Advanced Parkinson's Disease

Cystic fibrosis

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.